Marc Long
EXECUTIVE VP, R & D at MUSCULOSKELETAL TRANSPLANT · NJ · Healthcare
$558K
Peak Total Compensation
6
Years Tracked
7x
vs. Median Household
Marc Long has appeared in compensation disclosures over 6 years of available data (2017–2024). Total compensation changed from $333,533 to $557,606 - a 67.2% increase.
Peak total compensation of $557,606 equals 7x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2024 | MUSCULOSKELETAL TRANSPLANT | EXECUTIVE VP, R & D | $494,523 | $63,083 | $557,606 |
| 2022 | MUSCULOSKELETAL TRANSPLANT | EXEC R & D | $443,321 | $49,435 | $492,756 |
| 2020 | MUSCULOSKELETAL TRANSPLANT | EXEC R & D | $399,386 | $110,834 | $510,220 |
| 2019 | MUSCULOSKELETAL TRANSPLANT | EXEC R & D | $320,167 | $40,027 | $360,194 |
| 2018 | MUSCULOSKELETAL TRANSPLANT | VP R & D | $355,357 | $37,103 | $392,460 |
| 2017 | MUSCULOSKELETAL TRANSPLANT | VP R & D | $319,802 | $13,731 | $333,533 |
Peers at MUSCULOSKELETAL TRANSPLANT
| Name | Title | Peak Comp. |
|---|---|---|
| Joseph A Yaccarino | PRESIDENT / CEO | $979K |
| Bruce W Stroever | PRES - ENDED | $957K |
| Michael J Kawas | EXECUTIVE VP/ CFO | $763K |
| Beth Brett | SURGICAL CON | $685K |
| Martha Anderson | FORMER EXEC | $626K |
| Thomas C Shaffer | EXEC VP SALE | $611K |
| Floyd Vaughan | EXECUTIVE SPECIALIST - STAR | $574K |
| Sarah Brusch | EXECUTIVE SPECIALIST - STAR | $567K |
| Jodie Crabil | SURGICAL CON | $561K |
| Jennifer Birmingham | GENERAL COUNSEL | $548K |
Email Alerts
Get notified about Marc Long
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →